Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 8 studies | 20% ± 3% | |
naive B cell | 8 studies | 23% ± 4% | |
memory B cell | 3 studies | 17% ± 2% |
Insufficient scRNA-seq data for expression of GPR18 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 95% | 42.45 | 550 / 578 | 55% | 1.95 | 633 / 1155 |
esophagus | 69% | 18.79 | 998 / 1445 | 55% | 1.17 | 100 / 183 |
intestine | 85% | 79.66 | 819 / 966 | 35% | 1.28 | 184 / 527 |
stomach | 67% | 15.01 | 240 / 359 | 52% | 2.10 | 149 / 286 |
breast | 63% | 13.50 | 287 / 459 | 52% | 1.96 | 578 / 1118 |
kidney | 66% | 19.15 | 59 / 89 | 44% | 1.23 | 398 / 901 |
prostate | 94% | 33.58 | 231 / 245 | 16% | 0.48 | 81 / 502 |
thymus | 79% | 32.14 | 516 / 653 | 30% | 1.40 | 183 / 605 |
skin | 53% | 12.29 | 958 / 1809 | 52% | 2.62 | 244 / 472 |
bladder | 76% | 19.67 | 16 / 21 | 28% | 1.51 | 140 / 504 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.02 | 29 / 29 |
spleen | 100% | 607.68 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 256.07 | 925 / 929 | 0% | 0 | 0 / 0 |
uterus | 62% | 12.00 | 106 / 170 | 34% | 0.99 | 154 / 459 |
liver | 81% | 22.55 | 184 / 226 | 13% | 0.44 | 51 / 406 |
ovary | 51% | 10.67 | 92 / 180 | 24% | 0.43 | 104 / 430 |
adipose | 71% | 19.52 | 851 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 26% | 4.08 | 84 / 328 | 42% | 1.95 | 75 / 178 |
tonsil | 0% | 0 | 0 / 0 | 67% | 3.33 | 30 / 45 |
adrenal gland | 47% | 7.41 | 120 / 258 | 3% | 0.03 | 6 / 230 |
heart | 43% | 8.01 | 368 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 37% | 9.07 | 499 / 1335 | 0% | 0 | 0 / 0 |
brain | 16% | 2.19 | 420 / 2642 | 4% | 0.10 | 27 / 705 |
muscle | 11% | 1.76 | 86 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.30 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0002689 | Biological process | negative regulation of leukocyte chemotaxis |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0002305 | Biological process | CD8-positive, gamma-delta intraepithelial T cell differentiation |
GO_0002300 | Biological process | CD8-positive, alpha-beta intraepithelial T cell differentiation |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
Gene name | GPR18 |
Protein name | N-arachidonyl glycine receptor (G-protein coupled receptor 18) N-arachidonyl glycine receptor (NAGly receptor) (G-protein coupled receptor 18) |
Synonyms | GPCRW |
Description | FUNCTION: Receptor for endocannabinoid N-arachidonyl glycine (NAGly) . However, conflicting results about the role of NAGly as an agonist are reported . Can also be activated by plant-derived and synthetic cannabinoid agonists . The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase . May contribute to regulation of the immune system. Is required for normal homeostasis of CD8+ subsets of intraepithelial lymphocytes (IELs) (CD8alphaalpha and CD8alphabeta IELs)in small intstine by supporting preferential migration of CD8alphaalpha T-cells to intraepithelial compartment over lamina propria compartment, and by mediating their reconstitution into small intestine after bone marrow transplant (By similarity). Plays a role in hypotensive responses, mediating reduction in intraocular and blood pressure (By similarity). Mediates NAGly-induced process of reorganization of actin filaments and induction of acrosomal exocytosis . . |
Accessions | ENST00000397470.5 ENST00000397473.7 Q14330 ENST00000340807.3 ENST00000416594 Q5JUH9 ENST00000416594.2 |